In last trading session, Mira Pharmaceuticals Inc (NASDAQ:MIRA) saw 0.57 million shares changing hands with its beta currently measuring 2.07. Company’s recent per share price level of $1.45 trading at $0.03 or 2.11% at ring of the bell on the day assigns it a market valuation of $24.53M. That closing price of MIRA’s stock is at a discount of -245.52% from its 52-week high price of $5.01 and is indicating a premium of 64.83% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.08 million shares which gives us an average trading volume of 1.29 million if we extend that period to 3-months.
Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information
Upright in the green during last session for gaining 2.11%, in the last five days MIRA remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $1.45 price level, adding 5.23% to its value on the day. Mira Pharmaceuticals Inc’s shares saw a change of 27.19% in year-to-date performance and have moved 18.85% in past 5-day. Mira Pharmaceuticals Inc (NASDAQ:MIRA) showed a performance of 35.51% in past 30-days. Number of shares sold short was 0.89 million shares which calculate 0.33 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -224.25% during past 5 years.
Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders
Insiders are in possession of 19.80% of company’s total shares while institution are holding 5.76 percent of that, with stock having share float percentage of 7.18%. Investors also watch the number of corporate investors in a company very closely, which is 5.76% institutions for Mira Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 117.82 shares of worth $0.17 million or 0.70% of the total outstanding shares. The later fund manager was in possession of 68.72 shares on Mar 31, 2025 , making its stake of worth around $99649.0 in the company or a holder of 0.41% of company’s stock.